Y Intercept Hong Kong Ltd acquired a new position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,983 shares of the company's stock, valued at approximately $505,000.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. OneDigital Investment Advisors LLC acquired a new position in shares of Encompass Health in the 1st quarter valued at about $263,000. GAMMA Investing LLC raised its position in shares of Encompass Health by 21.5% during the 1st quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock valued at $240,000 after acquiring an additional 419 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in Encompass Health by 6.7% during the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock worth $276,000 after acquiring an additional 172 shares during the period. Cambridge Investment Research Advisors Inc. increased its position in Encompass Health by 30.1% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock worth $972,000 after buying an additional 2,218 shares during the period. Finally, Fifth Third Bancorp increased its position in Encompass Health by 88.7% in the first quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock worth $434,000 after buying an additional 2,017 shares during the period. Hedge funds and other institutional investors own 97.25% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on EHC shares. Barclays raised their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. Royal Bank Of Canada upped their price target on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research report on Monday, April 28th. KeyCorp raised their price objective on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 27th. UBS Group raised their price target on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a report on Monday, April 28th. Finally, Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $131.50.
Get Our Latest Stock Report on EHC
Insider Transactions at Encompass Health
In other Encompass Health news, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the sale, the chief executive officer directly owned 527,070 shares in the company, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the sale, the insider directly owned 11,958 shares of the company's stock, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by company insiders.
Encompass Health Stock Performance
Shares of EHC stock traded up $0.33 during trading on Thursday, reaching $110.29. 165,697 shares of the company's stock were exchanged, compared to its average volume of 800,437. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81. The firm's fifty day moving average price is $117.25 and its 200-day moving average price is $107.73. Encompass Health Corporation has a twelve month low of $82.74 and a twelve month high of $123.13. The stock has a market capitalization of $11.12 billion, a PE ratio of 22.79, a PEG ratio of 2.20 and a beta of 0.88.
Encompass Health Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.19 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.69%. This is a boost from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's dividend payout ratio is 14.05%.
Encompass Health Company Profile
(
Free Report)
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Stories

Before you consider Encompass Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.
While Encompass Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.